How Pharmaceutical Advertisements Lie About the Low Serotonin Hypothesis

Executive Summary

  • The FDA approves of drug companies and MDs misleading patients on the low serotonin hypothesis.

Introduction

Patients with both depression and a wide variety of health issues ranging from ADHD to social anxiety disorder are told that their illness is due to low serotonin. There is no evidence for this hypothesis.

How Pharma Misleads Consumers on the Scientific Consensus on Serotonin

This issue of the discrepancy between the scientific literature on serotonin and depression is covered in the following article Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature.

Wait One Second...

Why is The Article Not Viewable?

You are seeing this text instead of the article because of two potential reasons.

Reason #1: You are a Subscriber but Not Signed In

You can sign in by simply sending yourself a link to the email you signed in with by going here.

It's as easy as 1,2,3.  

You can read any article on the site as soon as you sign in.

Reason #2: You Are Not Yet Subscribed to the Site

This is a subscription site. That is how we pay for the research we do. We have to charge subscribers to access articles because, unlike WebMD, Healthline, or the Mayo Clinic, we don't allow pharmaceutical companies to write or edit our articles. 

You can access this and many other articles by becoming a subscriber.

How Do You Subscribe?

See the following article, which explains what you get with a subscription Subscribe to the Site.

You can be reading this article and many others like it in just a few minutes from now.